Notice of Exempt Offering of Securities, item 06b

> X0708 D LIVE 0001385818 AYTU BIOSCIENCE, INC 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO COLORADO 80112 (720) 437-6580 DELAWARE AYTU BIOSCIENCE, INC. Rosewind CORP Corporation true Joshua R. Disbrow c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Director Jarrett T. Disbrow c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Gregory A. Gould c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Executive Officer Michael Macaluso c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Gary V. Cantrell c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Carl C. Dockery c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director John A. Donofrio, Jr. c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 206 Englewood CO COLORADO 80112 Director Pharmaceuticals Decline to Disclose 06b false 2017-08-15 false true true false 0 Joseph Gunnar & Co., LLC 24795 Joseph Gunnar & Co., LLC 24795 30 Broad Street 11th Floor New York, NY NEW YORK 10004 All States false Fordham Financial Management, Inc. 20996 Fordham Financial Management, Inc. 20996 17 Battery Place, South Suite 643 New York NY NEW YORK 10004 All States false 11839995 11839995 0 false 70 1065600 0 In addition to the cash commission above, Issuer also issued warrants to purchase a number of shares of the Issuer's Common Stock equal to 10% of the aggregate amount of the offering. 0 Other than the payment of salaries and other customary compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. false AYTU BIOSCIENCE, INC /s/ Gregory A. Gould Gregory A. Gould Chief Financial Officer 2017-08-22

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Rosewind CORP makes a similar move, sign up!

Other recent filings from the company include the following:

General form for registration of securities under the Securities Act of 1933 - Sept. 22, 2017
General form for registration of securities under the Securities Act of 1933 - Sept. 5, 2017
Rosewind: Aytu Bioscience Provides Fiscal Fourth Quarter And Year-End 2017 Business Update - Aug. 31, 2017
Rosewind CORP Just Filed Its Annual Report: Note 14 – Subsequ... - Aug. 31, 2017
Rosewind: Aytu Bioscience Provides Fiscal Fourth Quarter And Year-End 2017 Business Update - Aug. 31, 2017

Auto Refresh

Feedback